COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING

被引：0
|
作者：
Suchankova, E.
Dolezal, T.
Pisarikova, Z.
Rychna, K. [2 ]
Bartaskova, D. [1 ]
机构：
[1] Charles Univ Prague, Fac Med 2, Prague, Czech Republic
[2] Novo Nordisk Sro, Prague 6, Czech Republic
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75002-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A405 / A406
页数：2
相关论文
共 50 条
  • [1] Cost-Effectiveness of Switching to Biphasic Insulin Aspart 30 from Human Insulin in Patients with Poorly Controlled Type 2 Diabetes in South Korea
    Lee, Kyoung Hee
    Seo, Se Jin
    Smith-Palmer, Jayne
    Palmer, James L.
    White, Jeremy
    Valentine, William J.
    [J]. VALUE IN HEALTH, 2009, 12 : S55 - S61
  • [2] An analysis of the cost-effectiveness of switching from biphasic human insulin 30, insulin glargine, or neutral protamine Hagedorn to biphasic insulin aspart 30 in people with type 2 diabetes
    Gupta, Vishal
    Baabbad, Ranya
    Hammerby, Eva
    Nikolajsen, Annie
    Shafie, Asrul Akmal
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (04) : 263 - 272
  • [3] Cost-effectiveness of Biphasic insulin aspart 30 versus human premix insulin for type 2 diabetes patients in a polish setting
    Aristides, M.
    Kotchie, R.
    Nielsen, C.
    Valentine, W. J.
    Scheijbeler, H.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A261 - A261
  • [4] PROJECTED COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 IN TYPE 2 DIABETES PATIENTS SWITCHED FROM BIPHASIC HUMAN INSULIN IN THE UNITED STATES
    Aagren, M.
    Thomsen, T. L.
    Knudsen, V. K.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A10 - A10
  • [5] Patients with type 2 diabetes mellitus poorly controlled on biphasic human insulin alone show improved glucose control with biphasic insulin aspart 30
    Shestakova, Marina V.
    Lebedev, Nikolay
    Bech, Ole M.
    [J]. DIABETES, 2008, 57 : A560 - A560
  • [6] Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China
    Palmer, James L.
    Gibbs, Meaghan
    Scheijbeler, Huib W. K. F. H.
    Kotchie, Robert W.
    Nielsen, Steffen
    White, Jeremy
    Valentine, William J.
    [J]. ADVANCES IN THERAPY, 2008, 25 (08) : 752 - 774
  • [7] SHORT AND LONG-TERM COST-EFFECTIVENESS OF SWITCHING THERAPY FROM BIPHASIC HUMAN INSULIN 30 TO BIPHASIC INSULIN ASPART 30 IN PEOPLE WITH TYPE-2 DIABETES
    Home, P. D.
    Soewondo, P.
    Hussein, Z.
    Shafie, A. A.
    AlRaddady, K.
    Baadbad, R.
    Hammerby, E.
    Nikolajsen, A.
    Andersen, M. F. B.
    Henriksen, O.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A164 - A164
  • [8] Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China
    James L. Palmer
    Meaghan Gibbs
    Huib WKFH Scheijbeler
    Robert W. Kotchie
    Steffen Nielsen
    Jeremy White
    William J. Valentine
    [J]. Advances in Therapy, 2008, 25 : 752 - 774
  • [9] Cost-effectiveness of biphasic insulin aspart 30 versus human premix insulin for type 2 diabetes patients in China
    Lynch, M.
    Scheijbeler, H.
    Kotchie, R.
    Neilsen, S.
    White, J.
    Valentine, W. J.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A262 - A262
  • [10] GLYCAEMIC CONTROL AND INSULIN UTILIZATION IN UK PATIENTS WITH TYPE 2 DIABETES INITIATED ON EITHER BIPHASIC INSULIN ASPART 30 OR BIPHASIC HUMAN INSULIN 30
    Fakhoury, W.
    Richter, H.
    Christensen, T.
    Thomsen, T. L.
    Irwin, D.
    Anderson, P.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A55 - A55
12345